PURPOSE
We sought to evaluate the association between 5 eye diseases (including glaucoma, cataract, congenital optic nerve disease, congenital retinal disease, and blindness/low vision) and mental illness in a pediatric population.
DESIGN
Cross-sectional study.
METHODS
A de-identified commercial insurance claims database, OptumLabs Data Warehouse, between January 1, 2007, and December 31, 2018, was used. Children and teens less than 19 years of age at the time of eye diagnosis were included. Demographics and mental illness claims were compared, looking at the association of mental illness and eye disease claims.
RESULTS
A total of 11,832,850 children and teens were included in this study with mean age of 8.04 ± 5.94 years at the first claim. Of the patients with at least 1 of the 5 eye diseases (n = 180,297), 30.5% had glaucoma (n = 54,954), 9.5% had cataract (n = 17,214), 21.4% had congenital optic nerve disease (n = 38,555), 26.9% had congenital retinal disease (n = 48,562), and 25.9% had blindness or low vision (n = 46,778). There was a statistically significant association, after adjusting for confounding variables, between at least 1 of the 5 eye diseases and schizophrenia disorder (OR = 1.54, 95% CI = 1.48-1.61, P < .001), anxiety disorder (OR = 1.45, 95% CI = 1.43-1.48, P < .001), depressive disorder (OR = 1.27, 95% CI = 1.25-1.29, P < .001), and bipolar disorder (OR = 1.27, 95% CI = 1.21-1.31, P < .001), but a reversed association with substance use disorder (OR = 0.88, 95% CI = 0.86-0.90, P < .001).
CONCLUSIONS
We found associations between eye disease in children and teens and mental illness. Understanding these relationships may improve mental illness screening and treatment in the pediatric population.
V isual impairment, and the presence of serious eye disease, has long been associated with a substantial decrease in quality of life. However, more recently, with increased attention given to mental health and quality of life during disease management, there has been a greater emphasis placed on the importance of understanding the impact of eye disease on mental illness. Mental illness has also been associated with systemic disease such as obesity, metabolic disorders, and cardiovascular disease, which may exacerbate underlying eye disease. Therefore, timely and effective diagnosis of psychological changes may have a profound effect on improvement in quality of life.
Multiple studies have found mood disorders, particularly depression and anxiety, to be associated with eye disease in adults. Macular degeneration, cataracts, glaucoma, chronic ocular discomfort from dry eye disease, , , , and ocular inflammatory disorders have all been associated with mental illness as a major source of disability. However, these studies have demonstrated inconsistent results in their depiction of the prevalence of mental illness among various ophthalmic patients, ranging from a prevalence of approximately 5% to over 50%. , , Furthermore, these studies have primarily focused on prevalence of depression and depressive symptoms, leaving other mental illnesses such as anxiety disorder, substance use disorder, bipolar disorder, schizophrenia, and other psychotic disorders unexplored. In addition, despite the impact of serious medical illness on children, studies demonstrating the impact of serious eye disease on mental illness have been limited. Prior studies investigating the impact of strabismus on children and teens have helped to lay the framework for discussing the overlap of eye conditions and mental health disorders in the pediatric population. Such studies have demonstrated that children with strabismus have a higher prevalence of alcohol use, depression, anxiety, social phobia, mental health disorders and hospitalizations, and broader psychosocial difficulties. These results further reinforce the importance of better understanding the association between serious eye disease and mental illness.
The purpose of this study was to investigate the association between serious eye diseases (glaucoma, cataract, congenital optic nerve disease, congenital retinal disease, and blindness/low vision) and mental illness disorders among children and teens in the OptumLabs Data Warehouse (OLDW), containing de-identified longitudinal claims data and health information on enrollees and patients representing a diverse population of ages, ethnicities, and geographical regions across the United States.
Methods
Data Source And Extraction
This cross-sectional study of a large commercial insurance claims database was deemed exempt from review by the institutional review board at the University of California Los Angeles, and all procedures were in accordance with the tenets of the Declaration of Helsinki. Data was derived from OLDW, a database that includes de-identified, longitudinal health information on enrollees and patients with a broad range of age, race and ethnicity, and geographical distribution across the United States. With claims data from commercial insurance and Medicare Advantage enrollees, excluding Medicare Part B (Fee for Service) and medical assistance programs, the claims data in OLDW is inclusive of medical and pharmacy claims, laboratory results, and enrollment records.
Medical claims data between January 1, 2007, and December 31, 2018, were extracted from the OLDW for all subjects with medical coverage during those dates. Given that the purpose of this study was to increase the breadth and depth of the understanding of the association of serious structural eye disease and mental illness, the most common serious eye conditions that presented in this database, as published previously, were included. Patients with eye disease (glaucoma, cataract, congenital optic nerve disease, congenital retinal disease, and blindness/low vision due to all causes) or mental illness (anxiety disorder, schizophrenia, bipolar disorder, depressive disorder, and substance use disorder) were identified based on diagnosis codes in the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) or the International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) as listed in Supplemental Table 1. The child’s age was calculated at the date of first claim for an eye disease. The age at first claim of each subtype of eye disease was also calculated. Controls consisted of children and teens without any eye disease diagnoses other than refractive error. Their age was calculated at the date of their first medical claim (between January 1, 2007 and December 31, 2018). Subjects were excluded from further analysis if they met the following criteria: those who were more than 18 years of age at the corresponding first claim; those with the corresponding first claims after January 1, 2018; 3); those without medical insurance; those with less than 6 months of medical insurance since their corresponding first claim; and those with eye diseases other than the 5 specific eye diseases mentioned.
In addition to age, baseline demographics including sex, race and ethnicity, education level of parents, household income, family net worth, geographic region, and type of insurance were also extracted. As a measure of general health, the presence or absence of medical comorbidities was also extracted, using a subset of the Agency for Healthcare Research and Quality (AHRQ) comorbidity variables selected based on their inclusion in the Pediatric Comorbidity Index, a model used to predict 1-year mortality in pediatric patients. These variables include septicemia, mycoses, cancer of the brain and nervous system, leukemias, coagulation and hemorrhagic disorders, diseases of white blood cells, epilepsy/convulsions, essential hypertension, hypertension with complications and secondary hypertension, conduction disorders, cardiac dysrhythmias, cardiac arrest and ventricular fibrillation, congestive heart failure/nonhypertensive, acute cerebrovascular disease, pneumonia, influenza, aspiration pneumonitis/food/vomitus, respiratory failure/insufficiency/arrest, nervous system congenital anomalies, intrauterine hypoxia and birth asphyxia, fracture of neck of femur, intracranial injury, fever of unknown origin, shock, and developmental disorders.
STATISTICAL ANALYSIS
Data extractions were conducted using SQL Software DBVisualizer Pro 10.0.15 (DbVis Software AB), and statistical analyses were performed using R (3.5.3) (R Foundation for Statistical Computing). Descriptive statistics were performed for children and teens with and without eye diseases. Continuous variables were compared using t tests, and categorical variables were compared using χ 2 tests. The unadjusted odds ratio for mental illness on eye disease was calculated with 95% confidence intervals using univariate logistic regression models. Adjusted effects were estimated using multivariable logistic regression models with potential confounding variables, including age, sex, race and ethnicity, education, family net worth, geographic region, and the presence of at least 1 of the comorbidities as an indication for the status of general health.
To examine the effect of eye disease on each mental illness, children and teens with other types of mental illnesses were excluded from the corresponding analysis, and children and teens without any mental illnesses served as the reference group in all the analyses. Similarly, when assessing the unique effect of each subtype of eye disease, children and teens with other subtypes of eye disease were further excluded so that those without any eye diseases were kept in the control group in all comparisons.
RESULTS
A total of 11,832,850 children and teens were included in this study. In all, 180,297 children and teens had been diagnosed with at least 1 of the 5 eye diseases (glaucoma, cataract, congenital optic nerve disease, congenital retinal disease, blindness or low vision), and 11,652,553 children and teens had no serious eye disease diagnoses during the study period ( Table 1 ). Table 1 shows characteristics of the enrolled children and teens. The mean age at first claim was higher in the eye disease group (11.0 ± 4.8 years) than in the control group (8.0 ± 5.9 years; P < .001) ( Table 1 ). The eye disease group had a slight predominance of female patients (50.2%), and a majority of patients were White (45.1%), came from a family of annual household income greater than or equal to $40,000 (47.8%), had point of service (POS) insurance (65.5%), and had at least 1 comorbidity (61.6%). There was a similar distribution of characteristics across patients with and without eye disease, although those without eye disease were less likely to have at least 1 medical comorbidity (61.6% vs 46.0%; P < .001).
Characteristics | Patients Without Eye Disease (n = 11,652,553) | Patients With at Least 1 of the 5 Eye Diseases (n = 180,297) | P |
---|---|---|---|
Age at First Claim, a y | First Claim a | First Eye Disease Claim a | <.001 |
Mean (SD) | 8.0 (5.9) | 11.0 (4.8) | |
Time from First Claim to Last Enrollment Date, y | <.001 | ||
Mean (SD) | 4.2 (3.2) | 3.9 (2.8) | |
Sex | <.001 | ||
Male | 5,919,595 (50.8%) | 89,738 (49.8%) | |
Female | 5,731,188 (49.2%) | 90,519 (50.2%) | |
Race and Ethnicity | <.001 | ||
Asian | 453,549 (3.9%) | 9,663 (5.4%) | |
Black | 762,199 (6.5%) | 13,013 (7.2%) | |
Hispanic | 955,136 (8.2%) | 15,233 (8.4%) | |
White | 5,755,047 (49.4%) | 81,397 (45.1%) | |
Unknown | 3,726,622 (32.0%) | 60,991 (33.8%) | |
Education | <.001 | ||
Less than 12th Grade | 35,256 (0.3%) | 503 (0.3%) | |
High School Diploma | 1,796,056 (15.4%) | 24,978 (13.9%) | |
Less than a Bachelor’s Degree | 4,459,012 (38.3%) | 64,257 (35.6%) | |
More than a Bachelor’s Degree | 2,134,778 (18.3%) | 38,611 (21.4%) | |
Unknown | 3,227,451 (27.7%) | 51,948 (28.8%) | |
Household Income | <.001 | ||
< $40,000 | 732,556 (6.3%) | 10,861 (6.0%) | |
$40,000 – $74,999 | 1,214,096 (10.4%) | 16,766 (9.3%) | |
$75,000 – $124,999 | 1,640,746 (14.1%) | 24,710 (13.7%) | |
$125,000 – $199,999 | 1,253,487 (10.8%) | 21,296 (11.8%) | |
$200,000 + | 1,142,923 (9.8%) | 23,463 (13.0%) | |
Unknown | 732,556 (6.3%) | 10,861 (6.0%) | |
Family Net Worth | <.001 | ||
< $25K | 1,519,594 (13.0%) | 20,327 (11.3%) | |
$25K-$149K | 1,610,897 (13.8%) | 21,368 (11.9%) | |
$150K-$249K | 838,076 (7.2%) | 11,832 (6.6%) | |
$250K-$499K | 1,265,207 (10.9%) | 19,841 (11.0%) | |
≥ $500K | 1,702,434 (14.6%) | 34,963 (19.4%) | |
Unknown | 4,716,345 (40.5%) | 71,966 (39.9%) | |
Census Region | <.001 | ||
Midwest | 3,057,701 (26.3%) | 37,476 (20.8%) | |
Northeast | 1,375,678 (11.8%) | 44,063 (24.5%) | |
South | 5,149,334 (44.3%) | 73,338 (40.8%) | |
West | 2,028,115 (17.5%) | 25,030 (13.9%) | |
Type of Insurance | <.001 | ||
EPO | 1,331,557 (11.4%) | 24,006 (13.3%) | |
HMO | 869,464 (7.5%) | 15,148 (8.4%) | |
IND | 108,378 (0.9%) | 1091 (0.6%) | |
OTHER | 247,448 (2.1%) | 2057 (1.1%) | |
POS | 7,832,967 (67.2%) | 118,148 (65.5%) | |
PPO | 1,262,739 (10.8%) | 19,847 (11.0%) | |
Presence of ≥1 Comorbidity | <.001 | ||
No | 6,288,355 (54.0%) | 69,197 (38.4%) | |
Yes | 5,364,198 (46.0%) | 111,100 (61.6%) |